Fig. 2From: HER2 exon 20 insertion mutations and myelosuppression in lung adenocarcinoma patient: a case report and response to trastuzumab deruxtecanThe curves of A white blood cell count and B platelet count after treatment. C Chest CT results (October 8th, 2018) showed that the mass image of the right lower lung was reduced, indicating partial response to Bevacizumab + Pemetrexed disodium + Carboplatin. D, E Chest CT results (December 27th, 2018 and April 1st, 2019) showed enlarged bilateral lung lesions, with no significant changes in lymph nodesBack to article page